1. Home
  2. MIRM vs CHEF Comparison

MIRM vs CHEF Comparison

Compare MIRM & CHEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRM
  • CHEF
  • Stock Information
  • Founded
  • MIRM 2018
  • CHEF 1985
  • Country
  • MIRM United States
  • CHEF United States
  • Employees
  • MIRM N/A
  • CHEF N/A
  • Industry
  • MIRM Biotechnology: Pharmaceutical Preparations
  • CHEF Food Distributors
  • Sector
  • MIRM Health Care
  • CHEF Consumer Discretionary
  • Exchange
  • MIRM Nasdaq
  • CHEF Nasdaq
  • Market Cap
  • MIRM 1.9B
  • CHEF 2.0B
  • IPO Year
  • MIRM 2019
  • CHEF 2011
  • Fundamental
  • Price
  • MIRM $44.27
  • CHEF $61.81
  • Analyst Decision
  • MIRM Strong Buy
  • CHEF Strong Buy
  • Analyst Count
  • MIRM 10
  • CHEF 6
  • Target Price
  • MIRM $60.80
  • CHEF $65.83
  • AVG Volume (30 Days)
  • MIRM 425.9K
  • CHEF 506.1K
  • Earning Date
  • MIRM 05-07-2025
  • CHEF 04-30-2025
  • Dividend Yield
  • MIRM N/A
  • CHEF N/A
  • EPS Growth
  • MIRM N/A
  • CHEF 66.38
  • EPS
  • MIRM N/A
  • CHEF 1.47
  • Revenue
  • MIRM $379,251,000.00
  • CHEF $3,870,472,000.00
  • Revenue This Year
  • MIRM $29.51
  • CHEF $8.01
  • Revenue Next Year
  • MIRM $20.27
  • CHEF $7.37
  • P/E Ratio
  • MIRM N/A
  • CHEF $42.49
  • Revenue Growth
  • MIRM 69.31
  • CHEF 7.85
  • 52 Week Low
  • MIRM $23.83
  • CHEF $35.59
  • 52 Week High
  • MIRM $54.23
  • CHEF $66.51
  • Technical
  • Relative Strength Index (RSI)
  • MIRM 56.45
  • CHEF 70.35
  • Support Level
  • MIRM $40.00
  • CHEF $52.16
  • Resistance Level
  • MIRM $47.43
  • CHEF $63.18
  • Average True Range (ATR)
  • MIRM 2.07
  • CHEF 2.05
  • MACD
  • MIRM 0.54
  • CHEF 0.94
  • Stochastic Oscillator
  • MIRM 65.27
  • CHEF 88.24

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

About CHEF The Chefs' Warehouse Inc.

The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.

Share on Social Networks: